Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Anderson Luiz-Ferreira has a total of 185 co-authors. Here are the top co-authors by number of shared publications:

  • Wagner Vilegas

    Universidade Estadual Paulista, Brasil

    14 shared publications
  • Felipe Meira De-Faria

    Centre for Social and Affective Neuroscience, Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden

    13 shared publications
  • Clélia Akiko Hiruma-Lima

    Department of Physiology, Institute of Bioscience, São Paulo State University, Botucatu, São Paulo, 18618-689, Brazil.

    12 shared publications
  • Alba Regina Monteiro Souza-Brito

    Department of Pharmacology, Faculty of Medical Sciences, State University of Campinas-UNICAMP, 13083-970, Campinas, SP, Brazil; Department of Structural and Functional Biology, Institute of Biology, State University of Campinas-UNICAMP, 13083-970, Campinas, SP, Brazil

    10 shared publications
  • Alba Regina Monteiro Souza Brito

    Gedson Rodrigues de Morais Lima, Flavia Danniele Frota Machado, Josean Fechine Tavares, José Maria Barbosa Filho, Leônia Maria Batista, Departamento de Ciências Farmacêuticas, Centro de Ciências da Saúde, Laboratório de Farmacologia do Trato Gastrintestinal, Universidade Federal da Paraíba (UFPB), Cidade Universitária, João Pessoa, Paraíba, CEP 58051-970, Brazil

    8 shared publications
  • Cláudia Helena Pellizzon

    Universidade Estadual Paulista, Brazil

    8 shared publications

Latest Publications

  • Herb-Drug Interactions

    by James O. Fajemiroye, Anderson Luiz-Ferreira, Roberto Saavedra-Rodríguez


  • System Overview from Physiological and Pathological Standpoints

    by Gustavo Rodrigues Pedrino, Luiza Toubas Chaul, Virgínia Farias Alves, Caroline Vitória de Lima Moreira, Anderson Luiz-Ferreira, James O. Fajemiroye

  • Open Access

    Rafoxanide negatively modulates STAT3 and NF‐κB activity and inflammation‐associated colon tumorigenesis

    by Teresa Pacifico, Carmine Stolfi, Lorenzo Tomassini, Anderson Luiz‐Ferreira, Eleonora Franzè, Angela Ortenzi, Alfredo Colantoni, Giuseppe S. Sica, Manolo Sambucci, Ivan Monteleone, et al.

    In the colorectal cancer (CRC) niche, the transcription factors signal transducer and activator of transcription 3 (STAT3) and nuclear factor‐κB (NF‐κB) are hyperactivated in both malignant cells and tumor‐infiltrating leukocytes (TILs) and cooperate to maintain cancer cell proliferation/survival and drive protumor inflammation. Through drug repositioning studies, the anthelmintic drug rafoxanide has recently emerged as a potent and selective antitumor molecule for different types of cancer, including CRC. Here, we investigate whether rafoxanide could negatively modulate STAT3/NF‐κB and inflammation‐associated CRC. The antineoplastic effect of rafoxanide was explored in a murine model of CRC resembling colitis‐associated disease. Cell proliferation and/or STAT3/NF‐κB activation were evaluated in colon tissues taken from mice with colitis‐associated CRC, human CRC cells, and CRC patient‐derived explants and organoids after treatment with rafoxanide. The STAT3/NF‐κB activation and cytokine production/secretion were assessed in TILs isolated from CRC specimens and treated with rafoxanide. Finally, we investigated the effects of TIL‐derived supernatants cultured with or without rafoxanide on CRC cell proliferation and STAT3/NF‐κB activation. The results showed that rafoxanide restrains STAT3/NF‐κB activation and inflammation‐associated colon tumorigenesis in vivo without apparent effects on normal intestinal cells. Rafoxanide markedly reduces STAT3/NF‐κB activation in cultured CRC cells, CRC‐derived explants/organoids, and TILs. Finally, rafoxanide treatment impairs the ability of TILs to produce protumor cytokines and promote CRC cell proliferation. We report the novel observation that rafoxanide negatively affects STAT3/NF‐κB oncogenic activity at multiple levels in the CRC microenvironment. Our data suggest that rafoxanide could potentially be deployed as an anticancer drug in inflammation‐associated CRC.


  • Open Access

    Das ciências da saúde para as ciências humanas e sociais: o uso da metanálise na pesquisa qualitativa em Educação

    by Patrícia De Sousa Oliveira, Anderson Luiz-Ferreira, Vanessa Therezinha Bueno Campos

    As revisões de literatura constituem parte importante de qualquer projeto de pesquisa. Podendo ser realizado de diferentes maneiras, também possibilita a obtenção de diferentes resultados, de acordo com a metodologia empregada. Este ensaio discute a abordagem qualitativa da metanálise enquanto instrumento interessante de análise crítica da produção científica obtida através da revisão sistemática da literatura. Amplamente difundido nas ciências da saúde, onde fundamenta a medicina baseada em evidências, a metanálise é o objeto desta pesquisa que defende a sua aplicação no campo das ciências humanas e sociais, especialmente na Educação, onde é capaz de agregar as dimensões de intencionalidade e significação na construção dos dados. Partindo dos objetivos de pesquisa, a metanálise qualitativa pode atuar como eixo orientador da construção dos dados desde a seleção da amostra até a leitura, análise, categorização e interpretação dos dados.

  • Open Access

    Special Issue “Drug Treatments for Inflammatory Bowel Diseases”

    by Anderson Luiz-Ferreira, Carmine Stolfi

    Inflammatory bowel diseases (IBD), including Crohn’s disease (CD) and ulcerative colitis (UC), are chronic idiopathic, relapsing and remitting inflammatory diseases that affect the gastrointestinal tract, causing significant morbidity and loss of quality of life in affected individuals


  • Open Access

    Metodologias Ativas de Ensino-aprendizagem e Educação Especial: Relato de uma Experiência em Fisiologia da Audição no Ensino Superior

    by Patricia de Sousa Oliveira, Cyrce Leonor Pereira-Costa, Ana Flávia Vigário, Karla Graziella Moreira, Anderson Luiz-Ferreira

    Nos últimos anos, temos observado um avanço nas políticas de acesso e permanência de jovens e adultos com necessidades educacionais especiais no Ensino Superior. A fim de atender a demanda destes alunos, professores têm buscado novas metodologias e materiais que possam facilitar os processos de ensino-aprendizagem. Neste contexto, o uso das metodologias ativas, ao colocar o estudante como centro das ações educativas e o conhecimento como resultado de um processo construído colaborativamente, tem se mostrado uma importante estratégia para a Educação Especial. A criação de ambientes e recursos, que possam ser explorados pelo estudante, possibilita interação, problematização e ressignificação do conhecimento. Diante disto, este trabalho teve como objetivo relatar o desenvolvimento de um recurso tátil e seu uso como metodologia ativa de ensino-aprendizagem de fisiologia da audição. Embora, movimentos mais dialógicos e interativos de aprendizagem possam ser desenvolvidos nas aulas, o ensino de fisiologia tradicionalmente se baseia no uso exclusivo de recursos audiovisuais, no qual alunos com deficiência visual não são assistidos adequadamente. Tal recurso foi confeccionado em biscuit, tendo suas principais estruturas envolvidas com a transdução auditiva contempladas. A utilização de materiais concretos adaptados permitiu aos estudantes explorar os conteúdos abordados, de forma a representar mentalmente o que foi tateado. Além disso, o modelo didático permitiu a interação entre os estudantes, a simulação do funcionamento do processo auditivo em condições normais e a problematização de contextos fisiológicos patológicos do sistema, possibilitando a participação ativa dos estudantes na construção do conhecimento.

  • Open Access

    TRAIL-Sensitizing Effects of Flavonoids in Cancer

    by Anderson Luiz-Ferreira, Teresa Pacifico, Álefe Cardoso Cruz, Federica Laudisi, Giovanni Monteleone, Carmine Stolfi

    Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) represents a promising anticancer agent, as it selectively induces apoptosis in transformed cells without altering the cellular machinery of healthy cells. Unfortunately, the presence of TRAIL resistance mechanisms in a variety of cancer types represents a major hurdle, thus limiting the use of TRAIL as a single agent. Accumulating studies have shown that TRAIL-mediated apoptosis can be facilitated in resistant tumors by combined treatment with antitumor agents, ranging from synthetic molecules to natural products. Among the latter, flavonoids, the most prevalent polyphenols in plants, have shown remarkable competence in improving TRAIL-driven apoptosis in resistant cell lines as well as tumor-bearing mice with minimal side effects. Here, we summarize the molecular mechanisms, such as the upregulation of death receptor (DR)4 and DR5 and downregulation of key anti-apoptotic proteins [e.g., cellular FLICE-inhibitory protein (c-FLIP), X-linked inhibitor of apoptosis protein (XIAP), survivin], underlying the TRAIL-sensitizing properties of different classes of flavonoids (e.g., flavones, flavonols, isoflavones, chalcones, prenylflavonoids). Finally, we discuss limitations, mainly related to bioavailability issues, and future perspectives regarding the clinical use of flavonoids as adjuvant agents in TRAIL-based therapies.


  • Open Access

    Anthelmintic Drugs as Emerging Immune Modulators in Cancer

    by Carmine Stolfi, Teresa Pacifico, Anderson Luiz-Ferreira, Giovanni Monteleone, Federica Laudisi

    Despite recent advances in treatment approaches, cancer is still one of the leading causes of death worldwide. Restoration of tumor immune surveillance represents a valid strategy to overcome the acquired resistance and cytotoxicity of conventional therapies in oncology and immunotherapeutic drugs, such as immune checkpoint inhibitors and immunogenic cell death inducers, and has substantially progressed the treatment of several malignancies and improved the clinical management of advanced disease. Unfortunately, because of tumor-intrinsic and/or -extrinsic mechanisms for escaping immune surveillance, only a fraction of patients clinically respond to and benefit from cancer immunotherapy. Accumulating evidence derived from studies of drug repositioning, that is, the strategy to identify new uses for approved or investigational drugs that are outside the scope of the original medical indication, has suggested that some anthelmintic drugs, in addition to their antineoplastic effects, exert important immunomodulatory actions on specific subsets of immune cell and related pathways. In this review, we report and discuss current knowledge on the impact of anthelmintic drugs on host immunity and their potential implication in cancer immunotherapy.


  • Open Access

    Rafoxanide sensitizes colorectal cancer cells to TRAIL-mediated apoptosis

    by Federica Laudisi, Teresa Pacifico, Claudia Maresca, Anderson Luiz-Ferreira, Sara Antonelli, Angela Ortenzi, Alfredo Colantoni, Antonio Di Grazia, Eleonora Franzè, Marco Colella, et al.


  • Open Access

    The importance of active surveillance of carbapenem-resistant Enterobacterales (CRE) in colonization rates in critically ill patients

    by Mabel Duarte Alves Gomides, Astrídia Marília de Souza Fontes, Amanda Oliveira Soares Monteiro Silveira, Daniel Chadud Matoso, Anderson Luiz Ferreira, Geraldo Sadoyama

    Objective: This study aimed to demonstrate the importance of active carbapenem-resistant Enterobacterales (CRE) surveillance and evaluate the prevalence of invasive infections, risk factors, and mortality risk in CRE-colonized patients. Methods: Retrospective cohort study analyzing 1,920 patients identified using an active CRE surveillance protocol, admitted to an adult intensive care unit in southeastern Brazil from January 2014 to December 2018. Results: There were 297 (15.47%) CRE colonized patients, with one colonized for every six control patients. CRE-colonized patients demonstrated an increased chance of infection (odds ratio [OR] 7.967, p < 0.001). Overall, 20.54% of the colonized patients presented invasive infection (81.96% due to Klebsiella pneumoniae). The colonization and infection ratio demonstrated the important role of the active CRE surveillance protocol. There were identified multiple risk factors for CRE colonization, including long-term mechanical ventilation (OR 1.624, p = 0.019) and previous exposure to aminopenicillins (OR 5.204, p < 0.001), carbapenems (OR 3.703, p = 0.017), cephalosporins (OR 12.036, p < 0.001), and fluoroquinolones (OR 5.238, p = 0.012). The mortality risk was significantly higher among colonized (OR 2.356, p < 0.001) and colonized-infected (OR 2.000, p = 0.009) patients and in those with Enterobacter cloacae colonization (OR 5.173, p < 0,001) and previous aminopenicillins exposure (OR 3.452, p = 0.007). Conclusions: Early detection of CRE colonization through screening testing proved to be an important tool to control CRE spread. However, observation over the years has shown no effective control of colonization and infection. The prevalence rates of CRE colonization and colonization-infection were high, as were the mortality rates. In conclusion, an active CRE surveillance protocol is essential, but its impact depends on the effective implementation of preventive measures and feedback between team members.